论文部分内容阅读
在成都高新技术产业开发区,中科院成都地奥制药公司是一家贷款60万元创建,管理人员不足50人的“小厂”。然而,经过六年拼搏,它创造了一串串惊人的数字:1994年据中国高新技术企业发展评价中心公布,地奥制药公司居1993年全国百强高新技术企业按利润总额排名第10位。现拥有资产2亿多元,是1988年建厂的400多倍。 据有关部门统计,中科院成都地奥制药公司荣誉产品“地奥心血康”,居全国名优特新药类产品销量的第二位,心血管病同类药用量的第一位。1994年又列为“国家基本药物”。获得中国科学院科技进步一等奖和科技开发高新技术进步三等奖,被国家科委、国家计委审定为“国家级新产品”。 这是一组闪光的数字。它记载着李伯刚含辛茹苦进行科技创业的历程。 1982年,中国科学院成都生物研究所的李伯刚率领6位科技人员,在课题经费远远不足的情况下,承担了中国科学院“六五”、“七五”重点科研课题——防治
In Chengdu Hi-Tech Industrial Development Zone, CAS Chengdu Austrian pharmaceutical company is a “small factory” with a loan of 600,000 yuan and a management staff of less than 50. However, after six years of hard work, it created a string of staggering figures: In 1994, according to the China High-tech Enterprise Development and Evaluation Center, Diou Pharmaceutical was ranked 10th among the top 100 high-tech enterprises in the country in terms of total profits in 1993. Now has assets of 200 million yuan, was built in 1988 400 times. According to statistics from the relevant departments, the honorary product of “Earth Austrian Medicine” from Chengdu Austrian pharmaceutical company, CAS, ranks the second in the sales volume of the national famous and new special medicine products, and the first among the similar medicinal quantities of cardiovascular diseases. In 1994, it was listed as “National Essential Drugs.” Won the first prize of progress in science and technology of Chinese Academy of Sciences and the third prize of high and new technology progress in science and technology. It was approved as “National New Product” by the State Science Commission and the State Development Planning Commission. This is a group of flash numbers. It chronicles Li Boyang’s hard work in science and technology. In 1982, Li Bogleg, a researcher at Chengdu Institute of Biology, Chinese Academy of Sciences, led six scientific and technological personnel. Under the circumstance of far insufficient funds for the project, he undertook the key scientific research projects of the “Sixth Five-Year Plan” and “Seventh Five-Year Plan”